Oncoprotein v-Myb and retinoic acid receptor α are mutual antagonists

Blood Cells, Molecules and Diseases

Volumn 24, Issue 2, 1998, Pages 239-250

  Zemanová, Karla ^a,b   Šmarda, Jan ^b  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Hematopoiesis; mim 1; Myb; Retinoic acid receptor

Indexed keywords

ONCOPROTEIN; RETINOIC ACID RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; GROWTH REGULATION; HEMATOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUAIL;

EID: 0032104638     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0189     Document Type: Article

References (49)

1. 1. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27-30, 1989.
2. 2. Orkin SH. Hematopoiesis: how does it happen? Curr Opin Cell Biol 7:870-877, 1995.
3. 3. Mucenski ML, McLain K, Kie, AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677-689, 1991.
4. 4. Introna M, Luchetti M, Castellano M, Arsura M, Golay J. The myb oncogene family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. Semin Cancer Biol 5:113-124, 1994.
5. 5. Lipsick JS. One billion years of Myb. Oncogene 13:223-235, 1996.
6. 6. Baluda MA, Goetz IE. Morphological conversion of cell cultures by Avian myeloblastosis virus. Virology 15:185-199, 1964.
7. 7. Moscovici C. Leukemic transformation with avian myeloblastosis virus: present status. Curr Top Microbiol Immunol 71:79-96, 1975.
8. 8. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936-2940, 1980.
9. 9. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684, 1991.
10. 10. Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukamia fuses RAR-α with a novel putative transcription factor, PML. Cell 66:663-674, 1991.
11. 11. Pandolfi PP, Grignani F, Alcalay M, et al. Structure and origin of the acute promyelocytic leukemia my1/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285-1292, 1991.
12. 12. Huang ME, Ye YC, Chen SR, et al. Use of all-transretinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572, 1988.
13. 13. Tsai S, Collins. A dominant-negative retinoic receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153-7157, 1993.
14. 14. Smarda J, Sugarman J, Glass C, Lipsick J. Retinoic acid α suppresses transformation by v-myb. Mol Cell Biol 15:2474-2481, 1995.
15. 15. Ibanez CE, Lipsick JS. Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. J Virol 62:1981-1988, 1988.
16. 16. Ibanez CE, Lipsick JS. Trans activation of gene expression by v-myb. Mol Cell Biol 10:2285-2293, 1990.
17. 17. Fu SL, Lipsick JS. FAETL motif required for leukemic transformation by v-Myb. J Virol 70: 5600-5610, 1966.
18. 18. Glass CK, Holloway JM, Devary OV, Rosenfeld MG. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54: 313-323, 1988.
19. 19. Baum C, Forster P, Hegewish-Becker S, Harbers K. An optimized electroporation protocol applicable to a wide range of cell lines. Biotechniques 17:1058-1062, 1994.
20. 20. Southern PJ, Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early gene promoter. J Mol Appl Genet 1:327-341, 1982.
21. 21. Smarda J, Lipsick JS. Dicistronic selection for nuclear proteins in living animal cells. Gene 137:145-149, 1993.
22. 22. Moscovici C, Zeller N, Moscovici MG. Continuous lines of AMV-transformed non-producer cells: growth and oncogenic potential in the chick embryo. In: Revoltella RF, Basilico C, Gallo RC, Pontieri GM, Rovera G, Subak-Sharpe JH, eds. Expression of Differentiatied Function in Cancer Cells. New York: Raven Press, Ltd., pp. 325-449, 1982.
23. 23. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713-733, 1979.
24. 24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
25. 25. Sleeman JP. Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8:1931-1941, 1993.
26. 26. Ness SA, Marknell A, Graf T. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59:1115-1125, 1989.
27. 27. Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 79:448-453, 1990.
28. 28. Breitman TR, Keene BR, Hemmi H. Retinoic acid-induced differentiation of fresh human leukaemia cells and the human myelomonocytic leukaemia cell lines, HL-60, U-937 and THP-1. Cancer Surv 2:263-291, 1983.
29. 29. Olsson IL, Breitman TR. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing-inducing agents. Cancer Res 42:3924-3927, 1982.
30. 30. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68:589-593, 1982.
31. 31. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393-403, 1978.
32. 32. Jetten AM, Jetten MER, Sherman MI. Stimulation of differentiation of several murine ambryonal carcinoma cell lines by retinoic acid. Exp Cell Res 124:381-391, 1979.
33. 33. Jetten AM, Nervi C, Saunders NA, Vollberg TM. Regulation of gene expression by retinoic acid in embryonal carcinoma PCC4.aza1R cells. In: Waxman S, Rossi GB, Takaku F, eds. The Status of Differentiation Therapy of Cancer. New York: Raven Press, Ltd. Vol. 2, pp. 265-272, 1993.
34. 34. Sherman MI, Matthei KI, Schindler J. Studies on the mechanism of induction of embryonal carcinoma cell differentiation by retinoic acid. Ann of the NY Acad Sci 359:192-199, 1981.
35. 35. Dai P, Akimaru H, Tanaka Y, et al. CBP as a transcriptional coactivator of c-Myb. Gene Dev 10:528-540, 1996.
36. 36. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414, 1996.
37. 37. Rascle A, Ferrand N, Gandrillon O, Samarut J. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor / cErbA and retinoid acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus. Mol Cell Biol 16:6338-6351, 1996.
38. 38. Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation, growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9:1807-1812, 1994.
39. 39. Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787-793, 1988.
40. 40. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene 6:165-167, 1991.
41. 41. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922, 1991.
42. 42. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311, 1991.
43. 43. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-1098, 1991.
44. 44. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69:119-128, 1992.
45. 45. Fornace AJ, Jackman J, Hollander MC, Hoffman-Liebermann B, Liebermann DA. Genotoxic-stress-response genes and growth-arrest genes gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann of the NYAcad Sci 663:139-154, 1992.
46. 46. Selvakumaran M, Lin HK, Tjin TSR, Reed JC, Liebermann DA, Hoffman B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14:2352-2360, 1994.
47. 47. Frampton J, Rambust T, Graf T. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Gene Dev 10:2720-2731, 1996.
48. 48. Taylor D, Badiani P, Weston K. A dominant interfering Myb mutant causes apoptosis in T cells. Gene Dev 10:2732-2744, 1996.
49. 49. Dini P, Eltman JT, Lipsick JS. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation. J Virol 69:2515-2524, 1995.